Search results for "cardiovascular benefit"
Taking a drink: what patients should know
Alcohol is associated with so many benefits and harms that it's hard to know where to start talking to patients about using it. One place might be alcohol misuse and abuse. Teach patients where they fall on the continuum of drinking behavior.
https://immattersacp.org/archives/2013/01/alcohol.htm
1 Jan 2013
Statins may be significantly overprescribed for primary prevention, computer model suggests
An analysis compared risk of drug-related events, including myopathy, hepatic dysfunction, and incident diabetes, to predicted cardiovascular benefit for men and women at various ages.
https://immattersacp.org/weekly/archives/2018/12/04/1.htm
4 Dec 2018
MKSAP Quiz: Follow-up for diabetes, hyperlipidemia, hypertension
A 68-year-old man is evaluated during a routine follow-up visit. Medical history is significant for type 2 diabetes mellitus, hyperlipidemia, hypertension, and aortofemoral bypass surgery 2 years ago. Following a physical exam, what is the most appropriate additional treatment?
https://immattersacp.org/weekly/archives/2022/11/15/3.htm
15 Nov 2022
Take a tiered approach to CVD
Primary care physicians' efforts are paying off as they promote primary prevention of cardiovascular disease, even in a time-pressed visit.
https://immattersacp.org/archives/2022/02/take-a-tiered-approach-to-cvd.htm
1 Feb 2022
Guideline issued on blood pressure management in CKD
The Kidney Disease: Improving Global Outcomes Work Group recommends targeting a standardized systolic blood pressure less than 120 mm Hg in patients with chronic kidney disease (CKD) who are not receiving dialysis, among other guidance.
https://immattersacp.org/weekly/archives/2021/06/22/4.htm
22 Jun 2021
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
The American College of Cardiology's new decision pathway also calls for repeated HbA1c screening and detailed clinician-patient risk discussions for patients with cardiovascular disease (CVD) who are diagnosed with type 2 diabetes.
https://immattersacp.org/weekly/archives/2018/12/04/2.htm
4 Dec 2018
NAFLD treatment starts with weight loss, then other modes
Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016
Shifting standards for hypertension
New hypertension guidelines are being developed by the American Heart Association (AHA) and the American College of Cardiology (ACC) that will incorporate new study results. At issue is how these results apply to the many types of patients who walk through the office door, including those with diabetes.
https://immattersacp.org/archives/2016/03/hypertension.htm
1 Mar 2016
Telmisartan and valsartan associated with fewer hospital admissions than other ARBs, study finds
In patients with diabetes, telmisartan and valsartan were associated with lower rates of hospitalization for cardiovascular events than other angiotensin-receptor blockers (ARBs), according to a recent retrospective study.
https://immattersacp.org/weekly/archives/2013/07/16/4.htm
16 Jul 2013
Reconciling conflicting diabetes guidance
ACP and other professional medical societies disagree on a proper target for the long-term benefits of glucose control.
https://immattersacp.org/archives/2018/06/reconciling-conflicting-diabetes-guidance.htm
1 Jun 2018